title: Policy development for Clostridium difficile.
abstract: The Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) was created at the height of the incidence of Clostridium difficile infection (CDI). This article describes the role of ARHAI in the evaluation of laboratory testing for CDI, a related consultation on the legal requirements for manufacturers of in vitro diagnostic medical devices, a CDI healthcare bundle and surveillance of CDI in children.
authors.affiliation: Department of Microbiology, Leeds Teaching Hospitals NHS Trust, The General Infirmary, Old Medical School, Leeds LS1 3EX, and Leeds Institute of Molecular Medicine, University of Leeds, UK. mark.wilcox@leedsth.nhs.uk
authors.forename: Mark H
authors.initials: MH
authors.lastname: Wilcox
mesh_terms: D026683:Advisory Committees / Q000458:organization & administration; D002648:Child; D016360:Clostridioides difficile / Q000472:pathogenicity*; D024881:Drug Resistance, Bacterial; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D007753:Laboratories / Q000331:legislation & jurisprudence* / Q000592:standards; D008828:Microbiological Techniques / Q000379:methods / Q000592:standards; D011933:Reagent Kits, Diagnostic / Q000592:standards*; D015203:Reproducibility of Results
chemical_list: D011933:Reagent Kits, Diagnostic